Revelation Quick Ratio from 2010 to 2026

REVBW Stock  USD 0.01  0  15.85%   
Revelation Biosciences Quick Ratio yearly trend continues to be fairly stable with very little volatility. Quick Ratio will likely drop to 1.85 in 2026. Quick Ratio is a measure of a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as (current assets - inventories) divided by current liabilities. View All Fundamentals
 
Quick Ratio  
First Reported
2010-12-31
Previous Quarter
3.09
Current Value
1.85
Quarterly Volatility
1.01354649
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Revelation Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Revelation Biosciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 36.1 K, Other Operating Expenses of 7.3 M or Total Operating Expenses of 7.3 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.76. Revelation financial statements analysis is a perfect complement when working with Revelation Biosciences Valuation or Volatility modules.
  
Build AI portfolio with Revelation Stock
Check out the analysis of Revelation Biosciences Correlation against competitors.
For more information on how to buy Revelation Stock please use our How to Invest in Revelation Biosciences guide.

Latest Revelation Biosciences' Quick Ratio Growth Pattern

Below is the plot of the Quick Ratio of Revelation Biosciences over the last few years. It is a measure of a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as (current assets - inventories) divided by current liabilities. Revelation Biosciences' Quick Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Revelation Biosciences' overall financial position and show how it may be relating to other accounts over time.
Quick Ratio10 Years Trend
Slightly volatile
   Quick Ratio   
       Timeline  

Revelation Quick Ratio Regression Statistics

Arithmetic Mean3.22
Geometric Mean2.98
Coefficient Of Variation31.49
Mean Deviation0.81
Median3.82
Standard Deviation1.01
Sample Variance1.03
Range2.9296
R-Value(0.62)
Mean Square Error0.68
R-Squared0.38
Significance0.01
Slope(0.12)
Total Sum of Squares16.44

Revelation Quick Ratio History

2026 1.85
2025 3.09
2024 3.43
2023 2.18
2022 1.22
2021 0.89

About Revelation Biosciences Financial Statements

Revelation Biosciences investors use historical fundamental indicators, such as Revelation Biosciences' Quick Ratio, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Revelation Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Quick Ratio 3.09  1.85 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Revelation Stock Analysis

When running Revelation Biosciences' price analysis, check to measure Revelation Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revelation Biosciences is operating at the current time. Most of Revelation Biosciences' value examination focuses on studying past and present price action to predict the probability of Revelation Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revelation Biosciences' price. Additionally, you may evaluate how the addition of Revelation Biosciences to your portfolios can decrease your overall portfolio volatility.